Showing results (51-60 of 268) with videos related to
Sort By:
Pageof 27
Arquivos Brasileiros De Cardiologia|May 7, 2025
Seven Deadly Sins in Hypertension Management: In-Depth Analysis of the Errors on a Journey from Riva-Rocci to Myocardial FibrosisClaudio Pinho, Heitor Moreno, José Francisco Kerr Saraiva, et al.Current Hypertension Reports|May 11, 2002
Resistant hypertensionDavid A Calhoun, Mohammad A Zaman, Mari K NishizakaSeminars in Nephrology|November 23, 2014
Pathophysiology and treatment of resistant hypertension: the role of aldosterone and amiloride-sensitive sodium channelsEric K Judd, David A Calhoun, David G WarnockAmerican Journal of Hypertension|October 24, 2003
Efficacy of low-dose spironolactone in subjects with resistant hypertensionMari Konishi Nishizaka, Mohammad Amin Zaman, David A CalhounJournal of Nature and Science|October 17, 2017
Refractory versus resistant hypertension: Novel distinctive phenotypesTanja Dudenbostel, Mohammed Siddiqui, Nitin Gharpure, et al.Hypertension (Dallas, Tex. : 1979)|March 17, 2004
Simvastatin prevents load-induced protein tyrosine nitration in overloaded heartsWilson Nadruz, Valquer Jose Lagosta, Heitor Moreno, et al.Arquivos Brasileiros De Cardiologia|October 30, 2014
Effects of PDE type 5 inhibitors on left ventricular diastolic dysfunction in resistant hypertensionAna Paula Cabral de Faria, Rodrigo Modolo, Beatriz Vaz Domingues Moreno, et al.Current Hypertension Reports|May 26, 2005
Aldosterone antagonism: an emerging strategy for effective blood pressure loweringMonique N Pratt-Ubunama, Mari K Nishizaka, David A CalhounCurrent Hypertension Reports|July 20, 2019
Resistant Hypertension Management: Comparison of the 2017 American and 2018 European High Blood Pressure GuidelinesGuido Grassi, David A Calhoun, Giuseppe Mancia, et al.Expert Review of Cardiovascular Therapy|May 24, 2006
Aldosterone antagonists: effective add-on therapy for the treatment of resistant hypertensionKrishna K Gaddam, Monique N Pratt-Ubunama, David A CalhounPageof 27